COVID 19 Vaccine Development Tools Market

Global COVID-19 Vaccine Development Tools Market by Technology (Laboratory Technology [Next Generation Sequencing, PCR & qPCR, Flow Cytometry, Spectrometry, Microscopy & Electron Microscopy, Preparative & Process Chromatography, Nucleic Acid Isolation & Purification, Transfection Electroporation, Cell Culture, and Automated Liquid Handling] and Online Technology), Applications (Vaccine Research, Vaccine Process Development, and Vaccine Quality Assurance/Quality Control), End-users (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organization (CROs), and Academic & Research Institutes), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Forecast 2021 – 2028

  • Report ID: HC-3470
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 47
  • No. Of Pages: 202
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global COVID-19 vaccine development tools market was valued USD 16 billion in 2020 and is estimated to expand at a CAGR of 8.6% during the forecast period, 2021- 2028. The SARS-CoV-2 infection curve has recently begun to plateau, notably in wealthy nations, despite the rapid discovery and implementation of vaccines. The variations of SARS-COV-2 have surfaced in 2020, necessitating re-testing of the immunization efficacy of first-generation vaccines, while current efforts are still focused on determining the optimum vaccine rollout strategy to address the unprecedented global vaccination programs. The life sciences industry is focusing on developing long-term recovery for the SARS-COV-2 infection.

Global COVID 19 Vaccine Development Tools Summary

Market Trends, Drivers, Restraints, and Opportunities

  • The crucial role of Artificial Intelligence (AI) in the COVID-19 vaccine is one of the key factors fueling the growth of the market.
  • Rising pool of alliances to expedite vaccine development and clinical testing and significant funding initiatives by government and commercial groups are some of the major factors fueling the industry expansion.
  • The current climate of expedited vaccine development and clinical testing has prompted vaccine developers and industry participants to collaborate, which is prompting the market growth.

Scope of the report:

The report on the global COVID-19 vaccine development tools market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Global COVID-19 Vaccine Development Tools Market - Industry Analysis, Size, Share, Growth, Trends And Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Technology (Laboratory Technology [Next Generation Sequencing, PCR & qPCR, Flow Cytometry, Spectrometry, Microscopy & Electron Microscopy, Preparative & Process Chromatography, Nucleic Acid Isolation & Purification, Transfection Electroporation, Cell Culture, and Automated Liquid Handling] and Online Technology), Applications (Vaccine Research, Vaccine Process Development, and Vaccine Quality Assurance/Quality Control), End-users (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organization (CROs), and Academic & Research Institutes)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered in the Report

Thermo Fisher Scientific, Inc., Celerion, Cole-Parmer Instrument Company, LLC, Pfizer Inc., and Sartorius AG

COVID-19 Vaccine Development Tools Market Segment Insights:

Laboratory technology segment to dominate the market

Based on technology, the market can be bifurcated into laboratory technology and online technology. The laboratory segment can be further divided into next generation sequencing, PCR & qPCR, flow cytometry, spectrometry, microscopy & electron microscopy, preparative & process chromatography, nucleic acid isolation & purification, transfection electroporation, cell culture, and automated liquid handling. The laboratory technology segment accounted for more than 95% market share revenue in 2020. Increasing use of laboratory technologies in vaccine research and development, such as PCR, cell culture, flow cytometers, and spectrometry, is estimated to aid in the market development. In 2020, PCR and qPCR is estimated to contribute most revenue to the laboratory technology segment. Widespread use of PCR technologies in vaccine surveillance programs and efficacy testing is driving the market segment. The online technology segment is expected to expand at a CAGR of 13% during the forecast period. Apart from the increased requirement for vaccine management and tracking systems, existing businesses are also pursuing the adoption of interactive online platforms that aid in R&D, driving the segment growth.

Vaccine research segment to hold a major market share

On the basis of applications, the market can be divided into vaccine research, vaccine process development, and vaccine quality assurance/quality control. In 2020, the vaccine research segment dominated the market, accounting for more than 40% market revenue. Several causes, including increased government financing, substantial research by universities, healthcare organizations, and increased corporate development techniques by notable pharmaceutical corporations, are driving the segment growth.

Global COVID 19 Vaccine Development Tools Applications

Pharmaceutical and biopharmaceutical segment to account a significant market share

In terms of end-users, the market can be categorized as pharmaceutical & biopharmaceutical companies, contract research organization (CROs), and academic & research institutes. The pharmaceutical and biopharmaceutical segment accounted for a significant market share in 2020. Existing vaccine development infrastructure of these companies is driving the segment growth The substantial share of the market segment can be due to pharmaceutical companies' strong investment skills, which aided in the rapid development of the COVID-19 vaccine. Large pharmaceutical corporations are cooperating with biotech companies to help them scale up the COVID-19 vaccine manufacturing method. The main goal of research institutes is to conduct studies in order to uncover unique solutions that can be employed in vaccine development. They're working on a number of tools and evaluating the data generated by them in order to produce vaccines more quickly.

Global COVID 19 Vaccine Development Tools End Users

Asia Pacific is estimated to account a large market share

Based on regions, the market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2020, Asia Pacific dominated the COVID-19 vaccine development tools market, accounting for more than 35% of the market revenue. The early identification of the novel coronavirus' genome utilizing modern sequencing techniques in the region was a crucial component in the rapid vaccine development for SARS-CoV-2. In 2020, North America had a revenue share of more than 25% of the market share. Several factors, including increased research and development efforts, funding initiatives, the presence of major players, rising COVID-19 cases, and a huge population base receiving COVID-19 vaccination have contributed to the regional market growth.

Global COVID 19 Vaccine Development Tools Region

Segments

Technology

  • Laboratory Technology
    • Next Generation Sequencing
    • PCR & qPCR
    • Flow Cytometry
    • Spectrometry
    • Microscopy & Electron Microscopy
    • Preparative & Process Chromatography
    • Nucleic Acid Isolation & Purification
    • Transfection Electroporation
    • Cell Culture
    • Automated Liquid Handling
  • Online Technology

Applications

  • Vaccine Research
  • Vaccine Process Development
  • Vaccine Quality Assurance/Quality Control

End-users

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organization (CROs)
  • Academic & Research Institutes

Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific, Inc.
  • Celerion
  • Cole-Parmer Instrument Company, LLC
  • Pfizer Inc.
  • Sartorius AG

 

Competitive Landscape

Key players in the market are Thermo Fisher Scientific, Inc., Celerion, Cole-Parmer Instrument Company, LLC, Pfizer Inc., and Sartorius AG.

To maintain their market position, market players are focusing on expanding their offers through intensive R&D and forming alliances and collaborations with other big companies.

Global COVID 19 Vaccine Development Tools Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. COVID-19 Vaccine Development Tools Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. COVID-19 Vaccine Development Tools Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. COVID-19 Vaccine Development Tools Market - Supply Chain
  4.5. Global COVID-19 Vaccine Development Tools Market Forecast
     4.5.1. COVID-19 Vaccine Development Tools Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. COVID-19 Vaccine Development Tools Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. COVID-19 Vaccine Development Tools Market Absolute $ Opportunity
5. Global COVID-19 Vaccine Development Tools Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
6. North America COVID-19 Vaccine Development Tools Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
7. Latin America COVID-19 Vaccine Development Tools Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
8. Europe COVID-19 Vaccine Development Tools Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
9. Asia Pacific COVID-19 Vaccine Development Tools Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
10. Middle East & Africa COVID-19 Vaccine Development Tools Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa COVID-19 Vaccine Development Tools Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa COVID-19 Vaccine Development Tools Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global COVID-19 Vaccine Development Tools Market: Market Share Analysis
  11.2. COVID-19 Vaccine Development Tools Distributors and Customers
  11.3. COVID-19 Vaccine Development Tools Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Thermo Fisher Scientific, Inc.
     11.4.2. Celerion
     11.4.3. Cole-Parmer Instrument Company, LLC
     11.4.4. Pfizer Inc.
     11.4.5. Sartorius AG

Technology

  • Laboratory Technology
    • Next Generation Sequencing
    • PCR & qPCR
    • Flow Cytometry
    • Spectrometry
    • Microscopy & Electron Microscopy
    • Preparative & Process Chromatography
    • Nucleic Acid Isolation & Purification
    • Transfection Electroporation
    • Cell Culture
    • Automated Liquid Handling
  • Online Technology

Applications

  • Vaccine Research
  • Vaccine Process Development
  • Vaccine Quality Assurance/Quality Control

End-users

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organization (CROs)
  • Academic & Research Institutes

Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific, Inc.
  • Celerion
  • Cole-Parmer Instrument Company, LLC
  • Pfizer Inc.
  • Sartorius AG

 

Key players in the market are Thermo Fisher Scientific, Inc., Celerion, Cole-Parmer Instrument Company, LLC, Pfizer Inc., and Sartorius AG.

To maintain their market position, market players are focusing on expanding their offers through intensive R&D and forming alliances and collaborations with other big companies.

Global COVID 19 Vaccine Development Tools Key Players

Buy Report